![](/img/cover-not-exists.png)
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy
Hirbe, Angela C., Eulo, Vanessa, Moon, Chang I., Luo, Jingqin, Myles, Stephanie, Seetharam, Mahesh, Toeniskoetter, Jacqui, Kershner, Tammy, Haarberg, Sasha, Agulnik, Mark, Monga, Varun, Milhem, MohammVolume:
137
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2020.06.016
Date:
September, 2020
File:
PDF, 1.02 MB
2020